Today, however, the father would answer, "Why, it's the ProFunds Biotechnology Ultrasector Fund, up 114.6%, child." The child would narrow her eyes and ask, "What's the No. 2 fund?" And the father would say, "Why, it's also the ProFunds Biotechnology Ultrasector Fund, up 112.5%, child."
There would then be a lengthy discussion of the differences between mutual fund share classes and the definition of "ultrasector," and the use of futures and options in mutual funds, at which point the tearful child would declare that Santa is dead and that there is no good in this world worth fighting for.
Top Mid Cap Stocks To Buy Right Now: Analytica Bio - Energy Corp (ABEC)
Analytica Bio-Energy Corp., formerly Uniwell Electronic Corporation, incorporated on January 12, 2004, is a company with water purification system. The Company was a shell company.
The Company focused on acquiring an active business. In September 2013, the Company changed its name to Analytica Bioenergy, Inc.
Advisors' Opinion:- [By Dan Burrows]
Most importantly, on days when this penny stock did see heavy volume, it tumbled — a classic red flag for the “dump” part of pump-and-dump schemes, which penny stocks are ripe for.
Top Penny Stocks: Analytica Bio-Energy Corp. (ABEC)YTD Performance: 29,300%
52-Week Range: $0.0017 – $0.50
Average Volume (3 months): 9,574
Market Cap: $10.6 million
Best Consumer Service Companies For 2014: TotalFinaElf S.A.(TOT)
TOTAL S.A., together with its subsidiaries, operates as an integrated oil and gas company worldwide. The company operates through three segments: Upstream, Downstream, and Chemicals. The Upstream segment engages in the exploration, development, and production of oil and natural gas. It also involves in the transportation, trade, and marketing of natural gas and liquefied natural gas (LNG), as well as in LNG re-gasification and natural gas storage operations. In addition, this segment engages in the shipping and trade of liquefied petroleum gas (LPG); power generation from gas-fired power plants, nuclear, or renewable energies; production, trade, and marketing of coal, as well as in solar power systems and technology operations. As of December 31, 2010, it had combined proved reserves of 10,695 Mboe of oil and gas. The Downstream segment involves in refining, marketing, trading, and shipping crude oil and petroleum products. It also produces a range of specialty products, s uch as lubricants, LPG, jet fuel, special fluids, bitumen, marine fuels, and petrochemical feedstock. This segment holds interests in 24 refineries located in Europe, the United States, the French West Indies, Africa, and China, as well as operates a network of 17,490 service stations. The Chemicals segment produces base chemicals, including petrochemicals and fertilizers, as well as engages in rubber processing, resins, adhesives, and electroplating activities. TOTAL S.A. was founded in 1924 and is based in Paris, France.
Advisors' Opinion:- [By Dividend]
Total (TOT) has a market capitalization of $133.63 billion. The company employs 97,126 people, generates revenue of $246.559 billion and has a net income of $14.662 billion. Total�� earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $44.973 billion. The EBITDA margin is 18.24 percent (the operating margin is 12.29 percent and the net profit margin 5.95 percent).
Best Consumer Service Companies For 2014: Warner Chilcott plc(WCRX)
Warner Chilcott Public Limited Company, a specialty pharmaceutical company, together with its subsidiaries, engages in the development, manufacture, and promotion of branded pharmaceutical products focusing on the women?s healthcare, gastroenterology, dermatology, and urology markets in North America and western Europe. Its principal products include ACTONEL for the prevention and treatment of postmenopausal osteoporosis; ATELVIA for the treatment of postmenopausal osteoporosis; LOESTRIN 24 FE and LO LOESTRIN FE, which are oral contraceptives for the prevention of pregnancy; ESTRACE cream, a vaginal cream for the treatment of vaginal and vulvar atrophy; ASACOL for the treatment of ulcerative colitis for orally administered 5-aminosalicylic acid products and maintenance of remission; ASACOL HD for the treatment of moderately active ulcerative colitis; DORYX, a tetracycline-class oral antibiotic for the treatment of severe acne; and ENABLEX for the treatment of overactive b ladder. The company markets its products and services through wholesale pharmaceutical distributors, and retail drug store chains. It has a strategic collaboration agreement with Sanofi-Aventis U.S. LLC. Warner Chilcott Public Limited Company was founded in 1968 and is headquartered in Dublin, Ireland.
Advisors' Opinion:- [By Sean Williams]
What: Shares of Warner Chilcott (NASDAQ: WCRX ) , a branded pharmaceutical company focused on women's health care, shot higher by as much as 20% after the company reported its first-quarter earnings results, and on news that it could be a buyout target.
- [By Rich Smith]
On Friday, shares of branded pharmaceutical manufacturer Warner Chilcott (NASDAQ: WCRX ) jumped 20% in response to rumors that the company was in talks to sell itself to larger rival Actavis (NYSE: ACT ) . Warner also reported steady earnings, where a decline had been expected, and reiterated full-year guidance.
Best Consumer Service Companies For 2014: Utah Medical Products Inc.(UTMD)
Utah Medical Products, Inc. produces medical devices for the healthcare industry primarily in the United States and Europe. The company provides labor and delivery/obstetrics products, including fetal monitoring accessories, vacuum-assisted delivery systems, and other obstetrical tools, as well as neonatal intensive care products, such as DISPOSA-HOOD, an infant respiratory hood; DELTRAN PLUS, a blood pressure monitoring system; and GESCO, a biocompatible silicone catheter. It also offers umbilical vessel and artery, thermosensitive polyurethane, and peripherally inserted central venous catheters; enteral feeding devices; DIALY-NATE, a disposable peritoneal dialysis set; PALA-NATE, a silicone oral protection device; and MYELO-NATE for obtaining cerebral spinal fluid samples. In addition, the company provides gynecology/urology/electrosurgery products comprising LETZ System to excise cervical intraepithelial neoplasia; FINESSE electrosurgical generator; FILTRESSE evacuators ; EPITOME, an electrosurgical scalpel; PATHFINDER PLUS, an endoscopic irrigation device; LIBERTY system to treat and control urinary incontinence in women; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal uterine bleeding; and LUMIN for manipulating the uterus. Further, it offers DELTRAN for blood pressure monitoring; and pressure monitoring accessories, components, and other molded parts. The company?s products are used in neonatal intensive care units, labor and delivery departments, and women?s health center in hospitals, as well as in outpatient clinics and physician's offices. It markets its products through direct sales representatives, independent manufacturers? representatives, specialty distributors, national hospital distribution companies, and other medical device manufacturers; and through other medical device companies and independent medical products distributors. The company was founded in 1978 and is headquar tered in Midvale, Utah.
Advisors' Opinion:- [By John Udovich]
On Thursday, small cap infertility stock OvaScience Inc (NASDAQ: OVAS) surged 23.63% plus shares are up 372.9% since the start of the year���meaning its worth taking a closer look at the stock along with the performance of female or reproductive health stocks the Female Health Co (NASDAQ: FHCO) and�Utah Medical Products, Inc (NASDAQ: UTMD)�along with the Vanguard Health Care ETF (NYSEARCA: VHT).
- [By Geoff Gannon]
Utah Medical Products (UTMD)
There are some interesting stories on that list. Buffett watchers know The Washington Post. Ben Graham fans know National Presto. Anyone who follows net-nets is familiar with Micropac. If you��e a high ROC investor you��e probably come across Utah Medical Products (operating margins are over 30%). Atrion has one of the most interesting histories of value creation starting in the 1990s. And Arden is a grocer that earns a 15% return on equity in a bad year.
No comments:
Post a Comment